AU710634B2 - Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans - Google Patents

Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans Download PDF

Info

Publication number
AU710634B2
AU710634B2 AU70501/96A AU7050196A AU710634B2 AU 710634 B2 AU710634 B2 AU 710634B2 AU 70501/96 A AU70501/96 A AU 70501/96A AU 7050196 A AU7050196 A AU 7050196A AU 710634 B2 AU710634 B2 AU 710634B2
Authority
AU
Australia
Prior art keywords
zeaxanthin
cells
stereoisomer
carotenoids
macular degeneration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU70501/96A
Other languages
English (en)
Other versions
AU7050196A (en
Inventor
Kevin M. Garnett
Dennis L. Gierhart
Luis H. Guerra-Santos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZeaVision LLC
Original Assignee
Applied Food Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/551,153 external-priority patent/US5827652A/en
Priority claimed from US08/551,166 external-priority patent/US5854015A/en
Application filed by Applied Food Biotechnology Inc filed Critical Applied Food Biotechnology Inc
Publication of AU7050196A publication Critical patent/AU7050196A/en
Application granted granted Critical
Publication of AU710634B2 publication Critical patent/AU710634B2/en
Assigned to ZEAVISION, L.L.C. reassignment ZEAVISION, L.L.C. Alteration of Name(s) in Register under S187 Assignors: APPLIED FOOD BIOTECHNOLOGY, INC.
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU70501/96A 1995-10-31 1996-10-30 Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans Ceased AU710634B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/551153 1995-10-31
US08/551166 1995-10-31
US08/551,153 US5827652A (en) 1995-10-31 1995-10-31 Zeaxanthin formulations for human ingestion
US08/551,166 US5854015A (en) 1995-10-31 1995-10-31 Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion

Publications (2)

Publication Number Publication Date
AU7050196A AU7050196A (en) 1997-05-08
AU710634B2 true AU710634B2 (en) 1999-09-23

Family

ID=27069666

Family Applications (1)

Application Number Title Priority Date Filing Date
AU70501/96A Ceased AU710634B2 (en) 1995-10-31 1996-10-30 Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans

Country Status (14)

Country Link
JP (1) JPH10512594A (pt)
KR (1) KR100570251B1 (pt)
CN (1) CN1104235C (pt)
AR (1) AR004245A1 (pt)
AU (1) AU710634B2 (pt)
BR (1) BR9611488A (pt)
CZ (1) CZ297575B6 (pt)
FI (1) FI980947A (pt)
HU (1) HU223208B1 (pt)
NO (1) NO981698L (pt)
PL (1) PL185465B1 (pt)
RU (1) RU2197958C2 (pt)
WO (1) WO1997016175A1 (pt)
ZA (1) ZA969139B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8088363B2 (en) 2002-10-28 2012-01-03 Zeavision Llc Protection against sunburn and skin problems with orally-ingested high-dosage zeaxanthin
GB0501365D0 (en) 2005-01-21 2005-03-02 Promar As Compositions
AU2006213635B2 (en) * 2005-02-11 2010-06-17 Kalamazoo Holdings, Inc. A Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom
US8592662B2 (en) 2005-02-11 2013-11-26 Kalamazoo Holdings, Inc. Capsicum variety exhibiting a hyper-accumulation of zeaxanthin and products derived therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US308759A (en) * 1884-12-02 Curling hat-brims and machine therefor
DK0534955T3 (da) * 1989-08-30 1997-10-13 Applied Food Biotech Inc Fremgangsmåde til fremstilling af en zeaxanthinholdig sammensætning under anvendelse af en mikroorganisme af arten Flavobacterium multivorum.
US5310764A (en) * 1992-05-08 1994-05-10 Steven Baranowitz Treatment of age related macular degeneration with beta-carotene

Also Published As

Publication number Publication date
HUP9802314A2 (hu) 1999-04-28
PL185465B1 (pl) 2003-05-30
KR100570251B1 (ko) 2006-06-21
CZ130998A3 (cs) 1998-07-15
FI980947A0 (fi) 1996-10-30
PL326558A1 (en) 1998-09-28
HUP9802314A3 (en) 1999-05-28
HU223208B1 (hu) 2004-03-29
MX9605248A (es) 1998-06-30
CN1104235C (zh) 2003-04-02
CN1201388A (zh) 1998-12-09
RU2197958C2 (ru) 2003-02-10
AU7050196A (en) 1997-05-08
ZA969139B (en) 1997-09-25
AR004245A1 (es) 1998-11-04
NO981698D0 (no) 1998-04-16
FI980947A (fi) 1998-04-29
KR19990067180A (ko) 1999-08-16
CZ297575B6 (cs) 2007-02-07
JPH10512594A (ja) 1998-12-02
BR9611488A (pt) 1999-01-19
WO1997016175A1 (en) 1997-05-09
NO981698L (no) 1998-06-08

Similar Documents

Publication Publication Date Title
US5854015A (en) Method of making pure 3R-3'R stereoisomer of zeaxanthin for human ingestion
US5827652A (en) Zeaxanthin formulations for human ingestion
US5747544A (en) Method of using pure 3R-3'R stereoisomer of zeaxanthin to treat or prevent retinal degeneration in humans
AU2006266751B2 (en) Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions
US9849178B2 (en) Combination of carotenoids and epi-lutein
JPH10155459A (ja) アスタキサンチン含有飲食物
JPWO2008062559A1 (ja) 栄養補助食品、抗疲労作用剤又は持久力増強剤、機能性食品又は化粧料
JPH10276721A (ja) アスタキサンチン含有飲食物
CA2188983C (en) Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans
US7691406B2 (en) Zeaxanthin formulations for human ingestion
AU710634B2 (en) Pure 3R-3'R stereoisomer of zeaxanthin for treating macular degeneration in humans
WO1997016175A9 (en) Pure 3r-3'r stereoisomer of zeaxanthin for treating macular degeneration in humans
JP2001136959A (ja) 枯草菌菌体および／またはその産生物を含む培養物、これに由来する水溶性ビタミンｋ誘導体、これらを含む医薬、食品および飼料ならびにこれらの製造方法
MXPA96005248A (en) Pure 3r-3'r stereoisomer of zeaxantin to treat macular degeneration in human beings
JP2006070114A (ja) カロテノイド類含有抽出物の製法
JPH0826989A (ja) アレルギー症状の予防又は改善剤
Chandan et al. Formulation and stability enhancement using vitamin A encapsulation in ocular abnormalities: A scientific review